BMEA - CIK 0001840439
The table below shows Biomea Fusion, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $61.98M | $118.08M | $102.55M | $62.71M | $28.00M | $3.67M |
| SG&A | $19.33M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $25.98M |
| $23.59M |
| $20.92M |
| $13.67M |
| $1.66M |
| Operating income | -$83.51M | -$144.07M | -$126.14M | -$83.63M | -$41.67M | -$5.33M |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$61.80M | -$138.43M | -$117.25M | -$81.83M | -$41.57M | -$5.32M |
| EPS (diluted) | -$1.18 | -$3.83 | -$3.44 | -$2.80 | -$1.74 | -$0.51 |